Author:
ÇELİK Pınar,HAVLUCU Yavuz,KURHAN Fikret,MUEZZİNOGLU Talha,GÖKTALAY Tuğba,ŞAKAR COŞKUN Ayşın,YORGANCIOĞLU Arzu
Publisher
Celal Bayar Universitesi Saglık Bilimleri Enstitusu Dergisi
Subject
Industrial and Manufacturing Engineering,Materials Science (miscellaneous),Business and International Management
Reference14 articles.
1. Ko E, Lee S, Goodman A. Gemcitabine pulmonary toxicity in ovarian cancer. Oncologist 2008; 13(7): 807-11.
2. Shaib W, Lansigan F, Cornfeld D, Syrigos K, Saif MW. Gemcitabine-induced pulmonary toxicity during adjuvant therapy in a patient with pancreatic cancer. JOP 2008; 9(6): 708-14.
3. Baig J, Shokouh-Amiri M, Chan J, Chowdhery R, Danthurthy S, Venepalli NK. The Spectrum of Pulmonary Toxicity in Pancreatic Cancer Patients Receiving Gemcitabine Combination Chemotherapy. Case Rep Oncol. 2019;12(2):506-512.
4. Gupta N, Ahmed I, Steinberg H et al. Gemsitabine- induced pulmonary toxicity: Case report and review of the literature. Am J Clin Oncol 2002; 25: 96-100.
5. Pavlakis N, Bell DR, Millward MJ et al. Fatal pulmonary toxicity resulting from treatment with gemcitabine. Cancer 1997; 80: 286-291.